Repro Med Systems with ticker code (KRMD) now have 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 16 and 9 calculating the mean target price we have 11.25. Given that the stocks previous close was at 6.22 this would indicate that there is a potential upside of 80.9%. The 50 day MA is 4.93 and the 200 day MA is 7.6. The market cap for the company is $278m. Find out more information at: http://www.korumedical.com
Repro Med Systems, doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems was founded in 1980 and is headquartered in Chester, New York.
